Azathioprine plus exclusive enteral nutrition versus azathioprine monotherapy for the prevention of postoperative recurrence in patients with Crohn's disease: an open-label, single-centre, randomised controlled trial.
Ming DuanMengjie LuYanqing DiaoLei CaoQiong WuYuxiu LiuJianfeng GongWeiming ZhuYi LiPublished in: Journal of Crohn's & colitis (2024)
In high-risk CD patients, combining AZA with postoperative 3-month EEN reduces 1-year ER but may temporarily impact quality of life. Further large-scale, long-term studies are warranted.